Back to BlackRock, Inc. BlackRock, Inc.

SUPNSUPN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in SUPERNUS PHARMACEUTICALS INC

BlackRock, Inc. holds 9.4M shares of SUPN (SUPERNUS PHARMACEUTICALS INC), worth $434.9M as of 2026-Q2. The position was increased (+6.3% shares). SUPN represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$434.9M

Current Shares

9.4M

Total Value Change

+$73.3M

Total Shares Change

-647,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.4M
+6.3%
$434.9M0.0%$46.51
33
2026-Q1
Increased
8.8M
+0.7%
$454.7M0.0%$54.56
31
2025-Q4
Increased
8.7M
+0.4%
$434.2M0.0%$49.89
31
2025-Q3
Decreased
8.7M
-7.2%
$415.7M0.0%$47.60
0
2025-Q2
Decreased
9.4M
-3.3%
$295.3M0.0%$31.16
0
2025-Q1
Decreased
9.7M
-3.1%
$317.2M0.0%$32.29
0
2024-Q4
New
10M
-
$361.5M0.0%$36.91
43

Other major holders of SUPN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used